Paul Tiger > Freshfields Bruckhaus Deringer LLP > New York, United States > Lawyer Profile
Freshfields Bruckhaus Deringer LLP Offices
601 LEXINGTON AVENUE
31ST FLOOR
NEW YORK, NY 10022
NEW YORK
United States
- Firm Profile
- Go to...
Paul Tiger
Work Department
Corporate
Position
Corporate and M&A Partner
Career
Paul advises on complex public and private M&A transactions and private equity investments.
Paul also has deep experience with de-SPAC transactions and PIPE financings.
Both in connection with and separate from these transactions, he counsels companies and their boards on stockholder activism, corporate governance, and fiduciary duty considerations. Paul has been recognized as a Dealmaker of the Year by The American Lawyer (2023), among the 500 leading dealmakers in the United States by Lawdragon 500 (2021, 2022), as a rising star for M&A by Law360, and among leading lawyers for M&A and activism by Legal 500 and M&A by IFLR1000.
Memberships
Member of the New York State bar and the Oregon State Bar Certified Public Accountant (inactive).
Education
Stanford Law School, J.D. with distinction; Order of the Coif 2004
University of Oregon, B.A. summa cum laude 1999
Lawyer Rankings
United States > M&A/corporate and commercial > M&A: large deals ($1bn+)
Acting for the likes of international pharma corporations, tech providers, and energy conglomerates, the Freshfields Bruckhaus Deringer LLP team comprises a set of corporate specialists who cover matters ranging from cross-border transactions to takeover defense. Ethan Klingsberg and Damien Zoubek co-head the New York offering, with the former routinely advising special committees and boards of directors on impactful mergers and complex governance issues, while the latter is an expert on shareholder activism defense. Also in New York, Jenny Hochenberg frequently tackles transformative M&A transactions, Sebastian Fain is knowledgeable on joint ventures, and both Paul Tiger and Paul Humphreys focus on stockholder activism and all-stock mergers. Based in San Francisco, John Fisher has expertise in the life sciences sector. Joseph Halloum left the firm in August 2024.
Lawyer Rankings
Top Tier Firm Rankings
- M&A/corporate and commercial > Corporate governance
- Dispute resolution > International arbitration
- Dispute resolution > Corporate investigations and white-collar criminal defense
Firm Rankings
- Dispute resolution > International litigation
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- Dispute resolution > Securities litigation: defense
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Antitrust > Civil litigation/class actions: defense
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Antitrust > Merger control
- Tax > US taxes: non-contentious
- International trade and national security > CFIUS
- International trade and national security > Customs, export controls and economic sanctions
- Dispute resolution > General commercial disputes
- Media, technology and telecoms > Technology transactions
- Healthcare > Life sciences
- Finance > Commercial lending
- M&A/corporate and commercial > Shareholder activism